Related Experiment Videos
Pulse corticosteroid therapy with methylprednisolone or dexamethasone
1Department of Pediatrics, All India Institute of Medical Sciences, New Delhi.
Indian Journal of Pediatrics
|April 25, 2000
Summary
Intravenous pulse steroid therapy uses high-dose glucocorticoids for rapid immunosuppression. Methylprednisolone and dexamethasone appear similarly effective for conditions like lupus and nephrotic syndrome, requiring careful supervision due to potential side effects.
Area of Science:
- Pharmacology and Immunology
- Nephrology and Rheumatology
Background:
- Intravenous pulse steroid therapy involves supraphysiological doses of glucocorticoids.
- It is indicated for conditions requiring rapid immunosuppression and anti-inflammatory effects, such as systemic lupus erythematosus, pemphigus, renal transplantation, steroid-resistant nephrotic syndrome, and crescentic glomerulonephritis.
Purpose of the Study:
- To review the use and efficacy of intravenous pulse steroid therapy.
- To compare the use of methylprednisolone versus dexamethasone in specific clinical contexts.
Main Methods:
- Review of existing literature and clinical practice regarding intravenous pulse steroid therapy.
- Discussion of adverse reactions associated with high-dose glucocorticoid administration.
Main Results:
- High-dose steroid therapy is associated with significant adverse reactions, including hypertension, arrhythmias, hypokalemia, psychosis, and infections.
- Methylprednisolone is commonly used, but dexamethasone is frequently employed in India due to availability and cost.
- While controlled studies are lacking, methylprednisolone and dexamethasone appear to have similar efficacy.
Conclusions:
- Intravenous pulse steroid therapy should be reserved for selected cases under careful medical supervision.
- Both methylprednisolone and dexamethasone can effectively treat patients requiring high-dose intravenous steroid therapy.